| Sep 25 2024 |
Health Canada Solicits Comments on Plant-Based Egg Alternative Labeling Guidance |
Keller and Heckman LLP |
| Sep 25 2024 |
This Week in 340B: September 17 – 23, 2024 |
McDermott Will & Emery |
| Sep 24 2024 |
EPA Proposes Updates to Recommendations of Specifications, Standards, and Ecolabels for Federal Purchasing |
Bergeson & Campbell, P.C. |
| Sep 24 2024 |
FDA Issues Revised Guidance on the Control of Nitrosamine Impurities in Human Drugs |
Keller and Heckman LLP |
| Sep 24 2024 |
FDA Updates Produce Safety Rule Small Entity Compliance Guide |
Keller and Heckman LLP |
| Sep 24 2024 |
A Primer on Expungement, Pardons, and Sealing Criminal Records in Pennsylvania |
Norris McLaughlin P.A. |
| Sep 24 2024 |
Senate Proposal Would Weed Out Prior Marijuana Use for Federal Job Applicants |
Bradley Arant Boult Cummings LLP |
| Sep 20 2024 |
From Fentanyl to Freon: Customs and Border Protection Seizures |
Jackson Lewis P.C. |
| Sep 19 2024 |
EC Adopts REACH Restriction for PFHxA and Related Substances |
Bergeson & Campbell, P.C. |
| Sep 19 2024 |
Alabama CON Report - September 2024 |
Bradley Arant Boult Cummings LLP |
| Sep 19 2024 |
Landmark Mental Health Parity Final Rule: What Plan Sponsors and Insurers Need to Know |
McDermott Will & Emery |
| Sep 19 2024 |
FDA Release Results of Sampling of Retail Dairy-Free Dark Chocolate and Chocolate-Containing Products for Milk Allergen |
Keller and Heckman LLP |
| Sep 19 2024 |
U.S. Youth Vaping Rates Continue to Show Dramatic Decline |
Keller and Heckman LLP |
| Sep 19 2024 |
DEA Announces Marijuana Rescheduling Hearing Following Elections and the Stakes Are Hugely Consequential |
Bradley Arant Boult Cummings LLP |
| Sep 19 2024 |
This Week in 340B: September 10 – 16, 2024 |
McDermott Will & Emery |
| Sep 18 2024 |
Blank Rome State of the Cannabis Industry Panelist Interview Series: James Daley, Needham Bank Senior Vice President and Director Structured Finance |
Blank Rome LLP |
| Sep 18 2024 |
Health Canada Finalizes Brominated Vegetable Oil Ban |
Keller and Heckman LLP |
| Sep 18 2024 |
California Bans Most Hemp Products and Illuminates Battle Between Hemp and Marijuana Businesses |
Bradley Arant Boult Cummings LLP |
| Sep 18 2024 |
Four Strategies and Five Legal Arguments To Defend Your Company Against EPA’s Benzene Enforcement Initiative |
Beveridge & Diamond PC |
| Sep 18 2024 |
A Study in THC-O: Unpacking the Recent Anderson Case |
Norris McLaughlin P.A. |
| Sep 17 2024 |
Ubrelvy Untitled Letter – A Double Fault for AbbVie? Or Makeup Misread for FDA? |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 17 2024 |
Will Sustained Pressure on the 340B Program Finally Lead to Much Needed Reform? |
Mintz |
| Sep 17 2024 |
FDA and the Fountain of Youth: Regulatory Hurdles in the Longevity Biotech Community |
Womble Bond Dickinson (US) LLP |
| Sep 17 2024 |
Celanese v. ITC: How the On-Sale Bar Can Turn Sweet Sales into Spoiled Patents |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 17 2024 |
August 2024 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Sep 17 2024 |
Foggy Roads and Auto Accidents: Navigating Liability in Foggy Weather |
Buckfire Law |
| Sep 17 2024 |
The 340B Drug Pricing Program: Top Five Things to Know |
Foley & Lardner LLP |
| Sep 17 2024 |
NCC Requests Extra Time to Comment on FSIS Salmonella Rule |
Keller and Heckman LLP |
| Sep 16 2024 |
U.S. House Of Representatives Passes The BIOSECURE Act During “China Week” |
Squire Patton Boggs (US) LLP |
| Sep 16 2024 |
Understanding Preliminary Injunction: A Review of a Recent Federal Circuit Decision |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 16 2024 |
Cannabis and Civil Litigation: Has the Cannabis Industry Finally Met Its Most Dangerous Foe? |
Bradley Arant Boult Cummings LLP |
| Sep 13 2024 |
Federal Circuit Says No Timing Requirement to Qualify as A POSITA |
Foley & Lardner LLP |
| Sep 13 2024 |
McDermott+ Check-Up: September 13, 2024 |
McDermott Will & Emery |
| Sep 13 2024 |
USDA and CDFA Declare California Free of Invasive Fruit Flies |
Keller and Heckman LLP |
| Sep 12 2024 |
IARC Releases Its Priority Evaluation List for 2025-2029 |
Nelson Mullins |
